Patrick Kishi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Patrick Kishi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Addison B. Smartt
Mayo Clinic Alix School of Medicine, Mayo Clinic, Phoenix, AZ, USA
2 shared publications - Cody Petrie1 shared publication
- Colin Fred Greineder
Biointerfaces Institute, University of Michigan, Ann Arbor, MI, USA.
1 shared publication - Connor O'HAre
Department of Emergency Medicine, University of Michigan, Ann Arbor, MI, United States
1 shared publication Cynthia J. Price
Linder Dermatology and Skin Cancer Center, 6710 E. Camelback Rd., Suite 220, Scottsdale, AZ, 85251, USA
1 shared publicationDouglas Rappaport
1 shared publication
Latest Publications
- Open Access
- 26 July 2025
- Published by Elsevier in JEM Reports
- Vol. 4 (3)
Expedited evaluation of atypical aortic dissection with point of care ultrasound: A case report
- 26 July 2025
- Published by Elsevier in JEM Reports
- Vol. 4 (3)
Open AccessExpedited evaluation of atypical aortic dissection with point of care ultrasound: A case report
- Open Access
- 24 March 2024
- Published by Elsevier in WFUMB Ultrasound Open
- Vol. 2 (1)
Comparing pulmonary ultrasound findings when viewing lung pleura beneath costal cartilage compared to costal bones
- 24 March 2024
- Published by Elsevier in WFUMB Ultrasound Open
- Vol. 2 (1)
Open AccessComparing pulmonary ultrasound findings when viewing lung pleura beneath costal cartilage compared to costal bones
- 14 June 2018
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 34 (2) , 165-170
Life-Threatening Pancreatitis in Jehovah’s Witness Patients With Severe Anemia Treated Without Transfusions and by Interventional Radiology Techniques
Blood transfusions in anemic patients frequently are used for critically ill patients as a life-saving therapeutic maneuver. Jehovah’s Witness (JW) patients typically refuse blood transfusions due to religious beliefs. Numerous clinical reports, in a wide spectrum of medical specialties, have shown no greater morbidity or mortality in JW patients or others who refused transfusions compared to those patients who accept transfusions. We report our experience with two JW patients who presented with severe anemia and life-threatening pancreatitis. Despite undergoing percutaneous drainages by interventional radiology (IR) for complex pancreatic collections (and other IR drainages), neither patient suffered any adverse effect from the IR procedures, even though they refused blood transfusions. Our experience suggests that IR procedures also may be successful with this more limited blood product protocol.
- 14 June 2018
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 34 (2) , 165-170
Life-Threatening Pancreatitis in Jehovah’s Witness Patients With Severe Anemia Treated Without Transfusions and by Interventional Radiology Techniques
Blood transfusions in anemic patients frequently are used for critically ill patients as a life-saving therapeutic maneuver. Jehovah’s Witness (JW) patients typically refuse blood transfusions due to religious beliefs. Numerous clinical reports, in a wide spectrum of medical specialties, have shown no greater morbidity or mortality in JW patients or others who refused transfusions compared to those patients who accept transfusions. We report our experience with two JW patients who presented with severe anemia and life-threatening pancreatitis. Despite undergoing percutaneous drainages by interventional radiology (IR) for complex pancreatic collections (and other IR drainages), neither patient suffered any adverse effect from the IR procedures, even though they refused blood transfusions. Our experience suggests that IR procedures also may be successful with this more limited blood product protocol.
- Open Access
- 12 January 2018
- Published by Springer Nature in Drug Safety - Case Reports
- Vol. 5 (1) , 4
Life-Threatening Reaction with Topical 5-Fluorouracil
A 67-year-old man developed a suspected adverse drug reaction during treatment with topical 5-fluorouracil (5-FU) for multiple actinic keratosis of the face, neck, and forearms. The man received topical 5-FU at a dosage of 0.5% for the actinic keratoses. After 1 week, he developed extreme lethargy, fatigue, fever, and mouth erosions. Several days later, and after discontinuation of 5-FU, painful mucositis and systemic side effects occurred, meeting criteria for hospitalization because of dehydration and a 6.8 kg weight loss. Hematology/oncology was consulted, and a possible systemic 5-FU reaction, similar to reactions to intravenous chemotherapy seen with a dihydropyrimidine dehydrogenase deficiency was suggested. The patient was not taking any concurrent medications, and he refused dihydropyrimidine dehydrogenase deficiency testing.
- 12 January 2018
- Published by Springer Nature in Drug Safety - Case Reports
- Vol. 5 (1) , 4
Open AccessLife-Threatening Reaction with Topical 5-Fluorouracil
A 67-year-old man developed a suspected adverse drug reaction during treatment with topical 5-fluorouracil (5-FU) for multiple actinic keratosis of the face, neck, and forearms. The man received topical 5-FU at a dosage of 0.5% for the actinic keratoses. After 1 week, he developed extreme lethargy, fatigue, fever, and mouth erosions. Several days later, and after discontinuation of 5-FU, painful mucositis and systemic side effects occurred, meeting criteria for hospitalization because of dehydration and a 6.8 kg weight loss. Hematology/oncology was consulted, and a possible systemic 5-FU reaction, similar to reactions to intravenous chemotherapy seen with a dihydropyrimidine dehydrogenase deficiency was suggested. The patient was not taking any concurrent medications, and he refused dihydropyrimidine dehydrogenase deficiency testing.